# The Value of IVL Compared To OPN Non-Compliant Balloons for Treatment of RefractorY Coronary Lesions (VICTORY) Trial

Study · id `cardio:ct-nct05346068` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05346068](<https://clinicaltrials.gov/study/NCT05346068>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05346068

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 280 participants.

## Technical summary

Registry record NCT05346068. Randomized; single masking; primary purpose treatment. Start 2022-11-22 (actual); primary completion 2025-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 280 participants (planned count; ClinicalTrials.gov record NCT05346068, source copy `cardio:ctgov-nct05346068-2024-06-18`, retrieved 2026-10-26)
- Started: 2022-11-22 (actual) (ClinicalTrials.gov record NCT05346068, source copy `cardio:ctgov-nct05346068-2024-06-18`, retrieved 2026-10-26)
- Primary completion: 2025-12-31 (anticipated) (ClinicalTrials.gov record NCT05346068, source copy `cardio:ctgov-nct05346068-2024-06-18`, retrieved 2026-10-26)
- Completion: 2028-05-30 (anticipated) (ClinicalTrials.gov record NCT05346068, source copy `cardio:ctgov-nct05346068-2024-06-18`, retrieved 2026-10-26)
- Countries: Switzerland (ClinicalTrials.gov record NCT05346068, source copy `cardio:ctgov-nct05346068-2024-06-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05346068-2024-06-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Value of IVL Compared To OPN Non-Compliant Balloons for Treatment of RefractorY Coronary Lesions (VICTORY) Trial
- Acronym: VICTORY
- Condition: Coronary Disease
- Condition: Coronary Artery Disease
- Condition: Calcific Coronary Arteriosclerosis
- Condition: Stent Restenosis
- Condition: Coronary Artery Calcification
- Intervention (Device): OPN™ NCB Super High Pressure PCI Balloon
- Intervention (Device): Shockwave™ C2 IVL Catheter
- Lead sponsor: Luzerner Kantonsspital
- Lead sponsor class: OTHER
- Collaborator: Hôpital Fribourgeois
- Collaborator class: OTHER
- Collaborator: Hamilton General Hospital
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: e80ce1c6225bd337551bc8ab4edaedb397664f94cb5f864b0b9d441edcef176f
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
